BDKRB1 and neoplasm: For instance, Lin’s group reported a series of peptidic B1R radiolabeled agonists and antagonists as novel PET radiotracers, using mice xenografted with HEK293T kidney cells highly overexpressing recombinant hB1R as tumor surrogates (see review [57]).